Trials / Completed
CompletedNCT02580370
Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 450 (actual)
- Sponsor
- Revance Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a safety and efficacy study of botulinum toxin type A in subjects with lateral canthal lines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Botulinum toxin type A | Topical botulinum toxin type A |
| BIOLOGICAL | Placebo comparator | Topical placebo comparator |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-07-01
- Completion
- 2016-08-01
- First posted
- 2015-10-20
- Last updated
- 2016-09-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02580370. Inclusion in this directory is not an endorsement.